Quantcast
Home » News
Home » News

Google's health startup forges venture with AbbVie

Published September 3, 2014 11:27 am

Technology • Each company will contribute $250 million to treatment of cancer, diseases.
This is an archived article that was published on sltrib.com in 2014, and information in the article may be outdated. It is provided only for personal research purposes and may not be reprinted.

San Francisco • Google's ambitious health startup is teaming up with biotechnology drugmaker AbbVie in a $500 million joint venture that will try to develop new ways to treat cancer and other diseases such as Alzheimer's.

The alliance announced Wednesday calls for Google Inc. and AbbVie Inc. to each invest $250 million in the project. They will split all expenses and any profits generated by the venture.

Calico, a company created by Google last year, will manage a team of scientists who will work at a research-and-development lab in the San Francisco Bay Area. The precise location and size of the new lab hasn't been determined.



AbbVie, a spin-off from Abbott Laboratories, will oversee the marketing of the drugs.

Calico is run by former Genentech CEO Arthur Levinson.

 

 

 

USER COMMENTS
Reader comments on sltrib.com are the opinions of the writer, not The Salt Lake Tribune. We will delete comments containing obscenities, personal attacks and inappropriate or offensive remarks. Flagrant or repeat violators will be banned. If you see an objectionable comment, please alert us by clicking the arrow on the upper right side of the comment and selecting "Flag comment as inappropriate". If you've recently registered with Disqus or aren't seeing your comments immediately, you may need to verify your email address. To do so, visit disqus.com/account.
See more about comments here.
comments powered by Disqus